AddexBio H460 cells (大细胞肺癌) H460 cells(C0016003)-细胞株/菌种-试剂-生物在线
苏州达麦迪生物医学科技有限公司
AddexBio H460 cells (大细胞肺癌) H460 cells(C0016003)

AddexBio H460 cells (大细胞肺癌) H460 cells(C0016003)

商家询价

产品名称: AddexBio H460 cells (大细胞肺癌) H460 cells(C0016003)

英文名称: H460 cells

产品编号: C0016003

产品价格: 0

产品产地: 美国

品牌商标: AddexBio

更新时间: null

使用范围: null

苏州达麦迪生物医学科技有限公司
  • 联系人 :
  • 地址 : 苏州高新区锦峰路8号1号楼501-503室
  • 邮编 :
  • 所在区域 : 上海
  • 电话 : 173****6276 点击查看
  • 传真 : 点击查看
  • 邮箱 : info@moreybio.com

Disease:

Large cell lung carcinoma 

Origin:

Derived from metastatic pleural effusion 

Species:

Homo sapiens 

Tissue:

Lung 

Morphology:

Epithelial 

Properties:

Adherent 

Cytogenic data:

This is a hypotriploid human cell line 

Patient:

Medium:

RPMI1640 + 10% FBS 

Subculture:

1:3 to 1:8 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37°C 

Freezing Medium:

Complete culture medium supplemented with 5% (v/v) DMSO 

Biosafety Level:
 I 
Sterility:

Bacteria: Negative 

Yeast: Negative 

Mycoplasma: Negative 

Pathogens:

HIV: Negative 

Hepatitis B: Negative 

Hepatitis C: Negative 

Isoenzymes:
 AK-1, 1; ES-D, 1; G6PD, B; GLO-I, 1-2; Me-2, 1; PGM1, 1; PGM3, 1 
DNA Profile (STR):
 Amelogenin: X,Y; CSF1PO: 11,12; D13S317: 13; D16S539: 9; D5S818: 9,10; D7S820: 9,12; THO1: 9.3; TPOX: 8; vWA: 17 
Mutations in H460 Cells 

Related cells by Organ:

A427 cells 

A549 cells 

Calu3 cells 

H460 cells 


References for H460 cells:

1. Lim, S. J., Choi, M. K., Kim, M. J., and Kim, J. K. Alpha-tocopheryl succinate potentiates the paclitaxel-induced apoptosis through enforced caspase 8 activation in human H460 lung cancer cells. Exp Mol Med, 41: 737-745, 2009. 

2. Pesic, M., Podolski, A., Rakic, L., and Ruzdijic, S. Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil. Invest New Drugs, 28: 482-492. 

3. Liu, H., Li, L., Li, X. Q., Liu, X. J., and Zhen, Y. S. Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells. Anticancer Drugs, 20: 41-49, 2009. 

4. Mollah, M. L., Song, J. C., Park, C. H., Lee, G. D., Hong, J. H., Ryoo, Z. Y., Lee, S., Chang, K. T., and Kim, K. S. Anticancer activity and apoptotic effects of Bulnesia sarmienti against human lung cancer H460 cells. Oncol Res, 18: 259-267, 2009. 

5. Borgovan, T., Bellistri, J. P., Slack, K. N., Kopelovich, L., Desai, M., and Joe, A. K. Inhibition of BCL2 expression and activity increases H460 sensitivity to the growth inhibitory effects of polyphenon E. J Exp Ther Oncol, 8: 129-144, 2009. 

6. Pesic, M., Andjelkovic, T., Bankovic, J., Markovic, I. D., Rakic, L., and Ruzdijic, S. Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R). Invest New Drugs, 27: 99-110, 2009.